84p 0.0 0.0%
Last Trade - 29/05/20
| Market Cap | £12.2m |
| Enterprise Value | £12.1m |
| Revenue | £14.1m |
| Position in Universe | 1463rd / 1825 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | TTM | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|---|
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2020
|
31st Dec 2021
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
InnovaDerma PLC is a holding company. The Company develops a range of male and female at-home and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation. It operates through hair and beauty division. Its products include Leimov Personal Hair Laser Starter Kit, Leimov Hair Treatment Pack, Leimov Bio Cleansing Shampoo, Leimov Thickening Conditioner, Leimov Scalp Therapy Day Treatment, Leimov Scalp Serum Night Treatment, Leimov Deep Cleansing Scalp and Body, Leimov Hair Treatment Pack for Her, Leimov Personal Hair Laser Starter Kit for Her, Leimov Vitality Shampoo, Leimov Follicle Boost Therapy, Leimov BioPlex Scalp Serum, Leimov Scalp and Body Exfoliating Spa, Leimo Instant Hair Introductory Pack, Leimo Instant Hair Regular Pack, Leimo Instant Hair Building Fiber, Skinny Tan-Ab Shader, Skinny Tan-Dermabrasion Pre-tan Primer, and Tan and Glow. It operates in the United Kingdom, the United States, Australia, New Zealand, the Philippines and South Africa.
| Last Annual | June 30th, 2019 |
| Last Interim | December 31st, 2019 |
| Incorporated | September 19, 2014 |
| Public Since | May 6, 2015 |
| No. of Shareholders: | n/a |
| No. of Employees: | 41 |
| Sector | Consumer Defensives |
| Industry | Personal & Household Products & Services |
| Index | |
| Exchange | London Stock Exchange (Full) |
| Shares in Issue | 14,496,633 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 27 Old Gloucester Street, LONDON, WC1N 3AX, United Kingdom |
| Web | https://www.innovaderma.com/ |
| Phone | + |
| Auditors | Greenwich & Co Audit Pvt Ltd |
As of 29/05/20, shares in Innovaderma are trading at 84p, giving the company a market capitalisation of £12.2m. This share price information is delayed by 15 minutes.
Shares in Innovaderma are currently trading at 84p and the price has moved by -9.68% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Innovaderma price has moved by 3.11% over the past year.
Of the analysts with advisory recommendations for Innovaderma, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Innovaderma is Not available. You can view the full broker recommendation list by unlocking its StockReport.
Innovaderma is scheduled to issue upcoming financial results on the following dates:
Innovaderma does not currently pay a dividend.
Innovaderma does not currently pay a dividend.
Innovaderma does not currently pay a dividend.
To buy shares in Innovaderma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Innovaderma are currently trading at 84p, giving the company a market capitalisation of £12.2m.
Here are the trading details for Innovaderma:
Based on an overall assessment of its quality, value and momentum, Innovaderma is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Innovaderma are currently priced at 84p. At that level they are trading at 0.114% discount to the analyst consensus target price of 84.10.
Analysts covering Innovaderma currently have a consensus Earnings Per Share (EPS) forecast of 0.095 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innovaderma. Over the past six months, the relative strength of its shares against the market has been 56.55%. At the current price of 84p, shares in Innovaderma are trading at 28.07% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Innovaderma PE ratio based on its reported earnings over the past 12 months is 10.67. The shares are currently trading at 84p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We were unable to find the directors for Innovaderma.
Here are the top five shareholders of Innovaderma based on the size of their shareholding:
